NGeneBio is moving ahead with plans to have the test cleared for diagnostic use in Korea, while envisioning a 2019 submission to the US FDA.
BGI won't be selling the gene-edited miniaturized pigs it developed, according to Technology Review.
The partners will explore the possibility of building a sequencing hub at the university for conducting local population cohort studies and diagnostic testing.
Later this year, BGI Europe and its partner Genome Diagnostics Nijmegen plan to offer complete diagnostic exome sequencing including clinical interpretation.
By combining in vivo and in vitro proximity ligation technologies, highly accurate and contiguous genomes can help accelerate more traditional, genetic-marker based crop breeding.
The potential cross-Pacific partnership could help the Seattle-based research institute discover and define cell types in the human brain.
BGI showed that its BGISEQ-500 can sequence a human genome, and that compared to the HiSeq 2500 it is comparable for SNP calling but worse for indels.
A brief recap of Genetics/Genomics news the week of Mar 17, 2017: BGI, Agilent Technologies, ReadCoor, and GeneNews
International research teams collaborated to create five fully functioning synthetic yeast chromosomes, taking them one step closer to a whole synthetic genome.
An international coalition sequenced the full genome of an Australian pitcher plant and compared it to both carnivorous and non-carnivorous plants.
At a meeting this week, researchers and others discussed the regulatory oversight needed for germline genome editing.
The US Food and Drug Administration has asked questions about Myriad Genetics' GeneSight test, according to Bloomberg.
Researchers report that neutrophil extracellular traps appear to binds gallstones together, according to New Scientist.
In Science this week: approach to infer genotype-by-environment interaction from genetic variants associated with phenotypic variability, and more.